Fri3ndMe

3 yrs

www.shoppelicansedge.com

Sindarius Thornwell Jersey, NBA New Orleans Pelicans Sindarius Thornwell Jerseys - Pelicans Store

Buy Sindarius Thornwell New Orleans Pelicans jerseys, t-shirts and more at the official online store. Get a new Sindarius Thornwell jersey or other gear, and check out the rest of our Sindarius Thornwell New Orleans Pelicans gear for any fan.

Comment

3 yrs

www.shopprorangers.com

Jesper Fast Men Jersey, New York Rangers Jesper Fast Men Jersey | NHL Jerseys

Shop for official New York Rangers Jesper Fast Men Jersey at the official online shop of the National Hockey League. The Jesper Fast Men Jersey is a step higher in quality, featuring tailored fit and twill numbers. We have the largest selection of Ra

Comment

3 yrs

Satta king | Sattaking | Satta result | Satta king online Satta king live | Satta king result
https://sattakingm.in
https://sattakingg.in/satta-king-leak-number.php
Satta king is a popular game that is played on daily basis. #satta A lot of #sattaking bet on the different games in the satta king. The results of these games are posted online. The company that runs these games usually fixes the timing of the results so that you https://sattakingm.in don't have to wait for hours to get the result. But, if you want to get the result faster, you can find a website https://sattakingg.in/

sattakingm.in

Satta king 2023 | Sattaking | Satta result | Satta king online | Satta king live | Satta king result

Get 2023 - Satta King, satta result, satta king up, sattaking, gali result, satta result up, black satta, satta king 786, satta gali, satta king gali, desawar result, faridabaad result, gaziabaad result king

Comment

3 yrs

The Satta King is a deadly bowling league paddle. That is what it was designed for. It is a full sized paddle that can do some serious damage to any novice players who don't have the slightest idea on how to handle or improve their skills on bowling. That is exactly the reason why many people love to
https://sattakingm.in/satta-ki....ng-ghaziabad-record-
#satta, #satta_king, #sattaking, #ajmerking, #sattakingfast, #playbazaar, #blacksattaking, #blacksatta , # shalimargame, # sattaking, #delhisattabajar, #दिल्लीदिसावर

sattakingm.in

Satta King Ghaziyabad chart 2019

Gaziyabad result, Gaziyabad Satta result, Satta king Gaziyabad result, Gaziyabad record chart 2019, Gaziyabad chart 2019, Satta king Gaziyabad chart 2019, Gaziyabad game record charts 2019, Gaziyabad Satta record chart 2019

Comment

3 yrs

What is the Satta Matka? | Pull Out a Chit
https://sattakingm.in/
https://sattakingg.in/

The Satta Matka is a gambling game that originated in India. It is based on the opening and closing rates of cotton.
It is a popular Satta King game that is played in many Indian states. It is legal in some states but illegal in others. It is a fun and exciting way to win money.

sattakingm.in

Satta king 2023 | Sattaking | Satta result | Satta king online | Satta king live | Satta king result

Comment

changed his profile picture

3 yrs

Comment

3 yrs

https://sattaking.vip/

Comment

3 yrs

The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% claims Roots Analysis

With an aim to counter the increasing number of cancer cases, researchers across the globe have developed AI-based solutions for the early diagnosis of a wide range of cancer indications.
Currently, various AI algorithms are being used in cancer imaging. Roots Analysis is pleased to announce the publication of its recent study, titled, “Artificial Intelligence in Oncology Market, 2022-2035.” It is worth highlighting that 26% of the players engaged in this domain are using both machine learning and deep learning technologies.

To request a sample copy / brochure of this report, please visit this
https://www.rootsanalysis.com/....reports/ai-in-oncolo

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this technology over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed overview of the overall market landscape of players engaged in the development of artificial intelligence in oncology software solutions.
 Elaborate profiles of prominent players that specialize in offering artificial intelligence in oncology- based software solutions.
 A competitiveness analysis of artificial intelligence in oncology- based software providers, based on supplier strength, portfolio diversity and portfolio strength.
 An in-depth analysis of patents related to artificial intelligence in oncology- based software solutions, filed / granted till date.
 An analysis of the partnerships that have been established in this domain, in the recent past.
 A detailed analysis of various investments made by players engaged in this domain, during the period 2017-2021.
 A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Type of Cancer
 Solid Malignancies
 Breast Cancer
 Lung Cancer
 Prostate Cancer
 Colorectal Cancer
 Brain Tumor
 Others
 Type of End-User
 Hospitals
 Pharma Companies
 Research Institutes
 Others
 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

Key companies covered in the report
 Ibex Medical Analytics
 Niramai
 Optellum
 Tempus Labs
 Paige
 Kheiron Medical Technologies

For additional details, please visit https://www.rootsanalysis.com/....reports/ai-in-oncolo

You may also be interested in the following titles:

1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035
2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Comment

3 yrs

The bioavailability enhancement services market is projected to grow at an annualized rate of 11.12% during the period 2021-2035, claims Roots Analysis

The bioavailability enhancement process is known to be fraught with several challenges, including its time and cost intensive nature; given the expertise available with service providers to improve pharmacokinetic properties of novel molecules, developers are actively outsourcing their requirements

Roots Analysis has announced the addition of “Bioavailability Enhancement Technologies and Services Market (2nd Edition), 2022-2035” report to its list of offerings

Considering the existing drug solubility and biocompatibility-related concerns and their impact on drug safety and patient compliance, the demand for bioavailability enhancement solutions has gained significant traction from the medical community. Drug developers have demonstrated a preference to continue relying on bioavailability enhancement service and technology providers, in order to optimize drug development cost and research timelines. Furthermore, driven by the large number of BCS class II and IV therapies in the current pipeline and growing demand for effective therapeutics, the bioavailability enhancement services market is expected to grow at a steady pace in the foreseen future.

Key Market Insights

~115 players currently claim to be engaged in providing bioavailability enhancement services
The bioavailability enhancement services market landscape is primarily characterized by the presence of small, mid-sized and large firms, which collectively constitute over 75% of the total share. Further, 45% of the service providers are based in North America, followed those having headquarters in Europe and Asia.

More than 75 bioavailability enhancement technologies are presently available in the market
Most (55%) of these technologies support solubility enhancement, followed by those providing support for sustained release drug delivery (46%). Additionally, nearly 70% of the technologies provide bioavailability enhancement services for solids, followed by liquids and fine particles / powders.

Partnership activity in this field has increased at a CAGR of nearly 35%, between 2013 and 2022
Mergers and acquisitions (~40%) emerged as the most common type of partnership models adopted by stakeholders engaged in this industry. Nearly 55% of the total deals were established post-2018, with the maximum activity being reported in 2021.

>9,600 patents related to bioavailability enhancement have been filed / granted, during 2003-2022
Majority (~80%) of the patents were filed as applications, followed by granted patents (20%). It is important to highlight that, nearly 1,200 patents were filed / granted in the year 2021. Further, 36% of the total patents were filed in North America, indicating the extensive R&D activity in this region.

4,700+ clinical trials evaluating bioavailability of drug candidates have been registered worldwide
Clinical research activity, in terms of number of trials registered, is reported to have increased at a CAGR of 24%, during the period 2010-2022. Of the total, more than 85% of the studies have already been completed, followed by active trials that are actively recruiting patients (~10%).

Technology evaluation framework provides a value addition matrix for bioavailability enhancement approaches currently employed by stakeholders
The framework highlights the implementation of several advanced as well as traditional bioavailability enhancement approaches and technologies at different stages of the drug development pathway. Further, it provides a detailed analysis on ease of implementation and associated risk in integrating such technologies, based on various parameters, such as number of technologies, number of approved drugs, trends highlighted in published literature and patents, and business models adopted by industry stakeholders.

Shifting focus of drug developers towards development of lipophilic drug compounds is anticipated to drive the demand for bioavailability enhancement technologies and services in the next 13 years
The outsourced commercial demand for bioavailability enhancement is projected to increase at a CAGR of ~10 %. Further, the current clinical demand for solid dosage form captures around 30% of the total demand.

North America and Europe are anticipated to capture more than 65% of the market share, by 2035
Owing to the high prevalence of diseases, increasing investments in formulation development research, and growing initiatives for drug discovery and personalized medicine in Asia, the bioavailability enhancement services market in Asia is likely to grow at a relatively faster pace (13.54%) in the long term. Further, in 2035, bioavailability enhancement services for new chemical entities are expected to dominate the market, capturing around 85% of the market share.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/....reports/198/request-

Key Questions Answered
 Who are the key players engaged in the bioavailability enhancement technologies and services market?
 Which are the key geographies where bioavailability enhancement technology and service providers are located?
 What are the recent developments and expected trends in the bioavailability enhancement industry?
 Which partnership models are commonly adopted by stakeholders offering bioavailability enhancement solutions?
 What is the evolving trend of publications focused on bioavailability enhancement technologies?
 Which companies are actively filing patents to drive innovation in the bioavailability enhancement market?
 What are the key market trends and driving factors that are likely to impact the growth of the bioavailability enhancement services market?
 How is the current and future opportunity likely to be distributed across key market segment?

The financial opportunity within the bioavailability enhancement services market has been analyzed across the following segments:

 Drug Class
 New Drug Approvals
 Generics

 BCS Classification
 BCS II Drugs
 BCS IV Drugs

 Bioavailability Enhancement Approach
 Solid Dispersion
 Size Reduction
 Lipid-based

 Dosage Form
 Liquids
 Solids
 Semi-Solids
 Fine Particles / Powders

 Key Geographies
 North America
 Europe
 Asia
 Latin America
 Middle East and North Africa (MENA)
 Rest of the World

The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), recent developments (including partnerships and collaborations) and an informed future outlook.
 Adare Pharma Solutions
 Ascendia Pharmaceuticals
 Catalent
 Lonza
 Lubrizol Life Science Health
 Pace Life Sciences
 Quotient Sciences
 WuXi STA (a subsidiary of WuXi AppTec)

For additional details, please visit
https://www.rootsanalysis.com/....reports/view_documen

You may also be interested in the following titles:
1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035
2. 4D Bioprinting Market : Industry Trends and Global Forecasts, 2022-2035

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

www.rootsanalysis.com

Request Sample - Bioavailability Enhancement Technologies and Services | Market Size | 2035

The space of bioavailability enhancement technologies and services, driven by the increase in number of BCS II and BCS IV molecules in early phases of development, is likely to grow at CAGR of ~11%, till 2035

Comment

3 yrs

Ashneer Grover represented as the company’s managing director and co-founder up until February 28, 2022, when he was made to step down and give up his positions there. In 2018, he and Shashvat Nakrani co-founded the business.
Read more: https://combonews.online/the-i....nspiring-success-sto

The Inspiring Success Story Of Former BharatPe Co-Founder And MD Ashneer Grover

combonews.online

The Inspiring Success Story Of Former BharatPe Co-Founder And MD Ashneer Grover

Ashneer Grover was born in Delhi on June 14, 1982, and he is a native of Delhi. Ashneer comes from a well-off family with a good education.

Comment

Discover posts

Sindarius Thornwell Jersey, NBA New Orleans Pelicans Sindarius Thornwell Jerseys - Pelicans Store

Jesper Fast Men Jersey, New York Rangers Jesper Fast Men Jersey | NHL Jerseys

Satta king 2023 | Sattaking | Satta result | Satta king online | Satta king live | Satta king result

Satta King Ghaziyabad chart 2019

Satta king 2023 | Sattaking | Satta result | Satta king online | Satta king live | Satta king result

Request Sample - Bioavailability Enhancement Technologies and Services | Market Size | 2035

The Inspiring Success Story Of Former BharatPe Co-Founder And MD Ashneer Grover